Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Clinical Briefs in Primary Care – March 1, 2006

March 1, 2006

View Archives Issues

  • Clinical Briefs in Primary Care

    There have been no new agents approved to treat gout for over 20 years. Because the plasma becomes supersaturated at a uric acid level of 6.0 mg/dL, it is felt that persons with a diathesis for tissue deposition of urate (gouty arthritis, tophi, or both) will optimize benefit by maintaining serum uric acid (SUA) below this level.